Ramesh Kumar
Directeur/Membre du Conseil chez OCUGEN, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Ramesh Kumar
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OCUGEN, INC. | Independent Dir/Board Member | 27/09/2019 | - |
| Directeur/Membre du Conseil | 27/09/2019 | - | |
| Comptroller/Controller/Auditor | - | 15/09/2023 | |
| Ocugen OpCo, Inc. | Directeur/Membre du Conseil | 01/06/2019 | - |
Historique de carrière de Ramesh Kumar
Anciens postes connus de Ramesh Kumar
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRAWS PHARMA, INC. | Directeur/Membre du Conseil | 29/04/2011 | 15/01/2019 |
| Directeur Général | 22/12/1998 | 15/01/2019 | |
| Fondateur | 22/12/1998 | 15/01/2019 | |
| President | 22/12/1998 | 21/06/2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | - | - |
Nextran
 Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Directeur/Membre du Conseil | - | - |
| Kimeragen, Inc. | Corporate Officer/Principal | - | - |
| Princeton University | Corporate Officer/Principal | - | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Formation de Ramesh Kumar
| University of Illinois | Doctorate Degree |
| Panjab University Chandigarh | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
| Inde | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Kimeragen, Inc. | Commercial Services |
Nextran
Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| Ocugen OpCo, Inc. |
- Bourse
- Insiders
- Ramesh Kumar
- Expérience